Oral whitish lichenoid lesions after treatment with intravenous immunoglobulins
- 1 November 2020
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (6) , e14383
Abstract
Click on the article title to read more.Keywords
This publication has 6 references indexed in Scilit:
- Epidermolysis Bullosa Acquisita: The 2019 UpdateFrontiers in Medicine, 2019
- Long-term results of rituximab–intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapyJournal of Dermatological Treatment, 2016
- Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidenceAutoimmunity Reviews, 2016
- Imunoglobulina intravenosa para tratamento de epidermólise bolhosa adquirida grave refratária a terapia imunossupressora convencionalAnais Brasileiros de Dermatologia, 2010
- Lichenoid/Interface Cutaneous Eruptions to IVIg with the Primary Infusion May Be Related to the Re-Regulation of Anti-Idiotype NetworkJournal of Cutaneous Medicine and Surgery, 1998
- Intravenous Immunoglobulin-Induced Lichenoid Dermatitis: A Unique Adverse ReactionMayo Clinic Proceedings, 1997